Gatorade/Miralax With or Without Bisacodyl Versus NuLytely for Colonoscopy Preparation
Study Details
Study Description
Brief Summary
The purpose of this study is to compare Nulytely (or Trilyte) with a Gatorade and Miralax combination for cleaning out the colon before colonoscopy. A laxative pill called Bisacodyl may also be used with the Gatorade and Miralax to see if it helps with the clean out process. We are trying to find out if either of these methods is more acceptable to the patient and does a better job cleaning out the colon for a colonoscopy.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 4 |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: Nulytely Nulytely (or Trilyte) 128 oz (1 gallon) to be consumed from about 5 PM to 9 PM the night before the colonoscopy. |
Drug: NuLytely
Nulytely (or Trilyte) 128 oz (1 gallon) to be consumed from about 5 PM to 9 PM the night before the colonoscopy.
|
Experimental: Gatorade/Miralax + Placebo Gatorade 64 oz (1/2 gallon), Miralax 306 g and a placebo (two 0.4 mg folic acid pills) to be consumed the day before the colonoscopy as follows: Miralax 51 g and placebo at 12 noon. Gatorade 64 oz mixed with Miralax 255 g from about 5 PM to 9 PM. |
Drug: Gatorade/Miralax
Gatorade 64 oz (1/2 gallon), Miralax 306 g to be consumed the day before your colonoscopy as follows: Miralax 51 g at 12 noon. Gatorade 64 oz mixed with Miralax 255 g from about 5 PM to 9 PM.
Drug: Placebo
Placebo (two 0.4 mg folic acid pills) to be consumed the day before the colonoscopy
|
Experimental: Gatorade/Miralax + Bisacodyl Gatorade 64 oz (1/2 gallon), Miralax 306 g and Bisacodyl 10 mg (two 5 mg pills) to be consumed the day before the colonoscopy as follows: Miralax 51 g and Bisacodyl 10 mg at 12 noon. Gatorade 64 oz mixed with Miralax 255 g from about 5 PM to 9 PM. |
Drug: Gatorade/Miralax
Gatorade 64 oz (1/2 gallon), Miralax 306 g to be consumed the day before your colonoscopy as follows: Miralax 51 g at 12 noon. Gatorade 64 oz mixed with Miralax 255 g from about 5 PM to 9 PM.
Drug: Bisacodyl
Bisacodyl 10 mg (two 5 mg pills) to be consumed the day before the colonoscopy at 12 noon.
|
Outcome Measures
Primary Outcome Measures
- The Quality of the Colon Preparation Will be Graded Using the Boston Bowel Preparation Scale [After Colonoscopy]
The Boston Bowel Preparation Scale measures cleanliness of the colon on a scale of 0 (very poor) to 9 (excellent).
Secondary Outcome Measures
- The Ottawa Scale for Colonoscopy Preparation Will be Reported and Compared Among the 3 Groups to Allow for Comparisons to Some of the Older Literature [After Colonoscopy]
Ottawa scale measures colon cleanliness on a scale from 14 (very poor) to 0 (excellent).
Eligibility Criteria
Criteria
Inclusion Criteria:
- Patients at least 18 years old planning to undergo an elective colonoscopy.
Exclusion Criteria:
-
Patients who are allergic or intolerant to any on the study drugs.
-
Pregnant patients.
-
Patients who required multiple day colon preparation in the past.
-
Patients with ileus, gastrointestinal obstruction, gastric retention, bowel perforation, toxic colitis or toxic megacolon would not be considered elective colonoscopies and are excluded.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Gastroenterology Services | Downers Grove | Illinois | United States | 60515 |
Sponsors and Collaborators
- Gastroenterology Services, Ltd.
Investigators
- Principal Investigator: David P Gerard, M.D., Gastroenterology Services, Ltd.
Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
None provided.- 1220100180
Study Results
Participant Flow
Recruitment Details | Subjects had their colonoscopy performed between February 2010 and February 2011 by one of three gastroenterologists (DG, JH, and MR) with 17 to 34 years of experience. Colonoscopies were scheduled to begin between 0800 h and noon in the gastrointestinal labs at our office or two community hospitals. |
---|---|
Pre-assignment Detail |
Arm/Group Title | Nulytely | Gatorade/Miralax + Placebo | Gatorade/Miralax + Bisacodyl |
---|---|---|---|
Arm/Group Description | Nulytely (or Trilyte) 128 oz (1 gallon) to be consumed from about 5 PM to 9 PM the night before the colonoscopy. | Gatorade 64 oz (1/2 gallon), Miralax 306 g and a placebo (two 0.4 mg folic acid pills) to be consumed the day before the colonoscopy as follows: Miralax 51 g and placebo at 12 noon. Gatorade 64 oz mixed with Miralax 255 g from about 5 PM to 9 PM. | Gatorade 64 oz (1/2 gallon), Miralax 306 g and Bisacodyl 10 mg (two 5 mg pills) to be consumed the day before the colonoscopy as follows: Miralax 51 g and Bisacodyl 10 mg at 12 noon. Gatorade 64 oz mixed with Miralax 255 g from about 5 PM to 9 PM. |
Period Title: Overall Study | |||
STARTED | 200 | 200 | 200 |
COMPLETED | 200 | 200 | 200 |
NOT COMPLETED | 0 | 0 | 0 |
Baseline Characteristics
Arm/Group Title | Nulytely | Gatorade/Miralax + Placebo | Gatorade/Miralax + Bisacodyl | Total |
---|---|---|---|---|
Arm/Group Description | Nulytely (or Trilyte) 128 oz (1 gallon) to be consumed from about 5 PM to 9 PM the night before the colonoscopy. | Gatorade 64 oz (1/2 gallon), Miralax 306 g and a placebo (two 0.4 mg folic acid pills) to be consumed the day before the colonoscopy as follows: Miralax 51 g and placebo at 12 noon. Gatorade 64 oz mixed with Miralax 255 g from about 5 PM to 9 PM. | Gatorade 64 oz (1/2 gallon), Miralax 306 g and Bisacodyl 10 mg (two 5 mg pills) to be consumed the day before the colonoscopy as follows: Miralax 51 g and Bisacodyl 10 mg at 12 noon. Gatorade 64 oz mixed with Miralax 255 g from about 5 PM to 9 PM. | Total of all reporting groups |
Overall Participants | 200 | 200 | 200 | 600 |
Age (Count of Participants) | ||||
<=18 years |
0
0%
|
0
0%
|
0
0%
|
0
0%
|
Between 18 and 65 years |
120
60%
|
120
60%
|
120
60%
|
360
60%
|
>=65 years |
80
40%
|
80
40%
|
80
40%
|
240
40%
|
Age (years) [Mean (Standard Deviation) ] | ||||
Mean (Standard Deviation) [years] |
60.2
(13.2)
|
59.7
(13.8)
|
61.3
(12.5)
|
60.4
(13.2)
|
Sex: Female, Male (Count of Participants) | ||||
Female |
81
40.5%
|
91
45.5%
|
99
49.5%
|
271
45.2%
|
Male |
119
59.5%
|
109
54.5%
|
101
50.5%
|
329
54.8%
|
Region of Enrollment (participants) [Number] | ||||
United States |
200
100%
|
200
100%
|
200
100%
|
600
100%
|
Outcome Measures
Title | The Quality of the Colon Preparation Will be Graded Using the Boston Bowel Preparation Scale |
---|---|
Description | The Boston Bowel Preparation Scale measures cleanliness of the colon on a scale of 0 (very poor) to 9 (excellent). |
Time Frame | After Colonoscopy |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Nulytely | Gatorade/Miralax + Placebo | Gatorade/Miralax + Bisacodyl |
---|---|---|---|
Arm/Group Description | Nulytely (or Trilyte) 128 oz (1 gallon) to be consumed from about 5 PM to 9 PM the night before the colonoscopy. | Gatorade 64 oz (1/2 gallon), Miralax 306 g and a placebo (two 0.4 mg folic acid pills) to be consumed the day before the colonoscopy as follows: Miralax 51 g and placebo at 12 noon. Gatorade 64 oz mixed with Miralax 255 g from about 5 PM to 9 PM. | Gatorade 64 oz (1/2 gallon), Miralax 306 g and Bisacodyl 10 mg (two 5 mg pills) to be consumed the day before the colonoscopy as follows: Miralax 51 g and Bisacodyl 10 mg at 12 noon. Gatorade 64 oz mixed with Miralax 255 g from about 5 PM to 9 PM. |
Measure Participants | 200 | 200 | 200 |
Mean (Standard Deviation) [units on a scale] |
7.86
(1.55)
|
8.05
(1.28)
|
7.99
(1.41)
|
Title | The Ottawa Scale for Colonoscopy Preparation Will be Reported and Compared Among the 3 Groups to Allow for Comparisons to Some of the Older Literature |
---|---|
Description | Ottawa scale measures colon cleanliness on a scale from 14 (very poor) to 0 (excellent). |
Time Frame | After Colonoscopy |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Nulytely | Gatorade/Miralax + Placebo | Gatorade/Miralax + Bisacodyl |
---|---|---|---|
Arm/Group Description | Nulytely (or Trilyte) 128 oz (1 gallon) to be consumed from about 5 PM to 9 PM the night before the colonoscopy. | Gatorade 64 oz (1/2 gallon), Miralax 306 g and a placebo (two 0.4 mg folic acid pills) to be consumed the day before the colonoscopy as follows: Miralax 51 g and placebo at 12 noon. Gatorade 64 oz mixed with Miralax 255 g from about 5 PM to 9 PM. | Gatorade 64 oz (1/2 gallon), Miralax 306 g and Bisacodyl 10 mg (two 5 mg pills) to be consumed the day before the colonoscopy as follows: Miralax 51 g and Bisacodyl 10 mg at 12 noon. Gatorade 64 oz mixed with Miralax 255 g from about 5 PM to 9 PM. |
Measure Participants | 200 | 200 | 200 |
Mean (Standard Deviation) [units on a scale] |
2.80
(2.24)
|
2.58
(2.47)
|
2.71
(2.47)
|
Adverse Events
Time Frame | up to 1 month after colonoscopy. | |||||
---|---|---|---|---|---|---|
Adverse Event Reporting Description | ||||||
Arm/Group Title | Nulytely | Gatorade/Miralax + Placebo | Gatorade/Miralax + Bisacodyl | |||
Arm/Group Description | Nulytely (or Trilyte) 128 oz (1 gallon) to be consumed from about 5 PM to 9 PM the night before the colonoscopy. | Gatorade 64 oz (1/2 gallon), Miralax 306 g and a placebo (two 0.4 mg folic acid pills) to be consumed the day before the colonoscopy as follows: Miralax 51 g and placebo at 12 noon. Gatorade 64 oz mixed with Miralax 255 g from about 5 PM to 9 PM. | Gatorade 64 oz (1/2 gallon), Miralax 306 g and Bisacodyl 10 mg (two 5 mg pills) to be consumed the day before the colonoscopy as follows: Miralax 51 g and Bisacodyl 10 mg at 12 noon. Gatorade 64 oz mixed with Miralax 255 g from about 5 PM to 9 PM. | |||
All Cause Mortality |
||||||
Nulytely | Gatorade/Miralax + Placebo | Gatorade/Miralax + Bisacodyl | ||||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | / (NaN) | / (NaN) | / (NaN) | |||
Serious Adverse Events |
||||||
Nulytely | Gatorade/Miralax + Placebo | Gatorade/Miralax + Bisacodyl | ||||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/200 (0%) | 1/200 (0.5%) | 0/200 (0%) | |||
Gastrointestinal disorders | ||||||
post-polypectomy bleed | 0/200 (0%) | 0 | 1/200 (0.5%) | 1 | 0/200 (0%) | 0 |
Other (Not Including Serious) Adverse Events |
||||||
Nulytely | Gatorade/Miralax + Placebo | Gatorade/Miralax + Bisacodyl | ||||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/200 (0%) | 0/200 (0%) | 0/200 (0%) |
Limitations/Caveats
More Information
Certain Agreements
All Principal Investigators ARE employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Name/Title | Dr. David Gerard |
---|---|
Organization | Gastroenterology Services |
Phone | 630 969 1167 |
davidpgerard@comcast.net |
- 1220100180